Status:
UNKNOWN
Mycoplasma Infection Rate and Macrolides Resistance in Children With Acute Respiratory Tract Infection
Lead Sponsor:
Shanghai Children's Medical Center
Collaborating Sponsors:
Beijing Children's Hospital
Tianjin Children's Hospital
Conditions:
Respiratory Tract Infections
Eligibility:
All Genders
28-18 years
Brief Summary
In recent years, mycoplasma pneumoniae caused more than 30% of respiratory infections in children in China, among which the detection rate of drug-resistant mycoplasma pneumoniae was higher than 90%. ...
Detailed Description
This research center is a cross-sectional investigation and study, 8 centers including Shanghai children's medical center recruit the outpatient respiratory infection cases into the group, 6 centers i...
Eligibility Criteria
Inclusion
- A) age: over 28 days, under 18 years old; B) diagnosis: outpatient diagnosis of common cold, acute bronchitis or post-infection cough and hospitalization cases consistent with community-acquired pneumonia.
- C) the guardian of the child (\< 8 years old) or the child (≥8 years old) can understand and be willing to participate in this study and sign a written informed consent.
Exclusion
- A)It is necessary to exclude underlying diseases associated with cardiovascular system, digestive system, nervous system, endocrine system, urinary system, immune system and genetic or chromosomal abnormalities.
- B) the children or their families refused to participate in the study.
Key Trial Info
Start Date :
November 28 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 31 2021
Estimated Enrollment :
2312 Patients enrolled
Trial Details
Trial ID
NCT04126304
Start Date
November 28 2019
End Date
May 31 2021
Last Update
October 15 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.